SLMO2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.65600000001653E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.452100E-02
Normal-vs-Stage2
3.76559999959447E-07
Normal-vs-Stage3
6.668400E-01
Normal-vs-Stage4
1.103550E-01
Stage1-vs-Stage2
2.013600E-01
Stage1-vs-Stage3
2.636800E-01
Stage1-vs-Stage4
3.202600E-01
Stage2-vs-Stage3
3.080600E-01
Stage2-vs-Stage4
8.332000E-01
Stage3-vs-Stage4
1.635650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.02040000005132E-06
Normal-vs-AfricanAmerican
9.687700E-02
Normal-vs-Asian
1.771580E-01
Caucasian-vs-AfricanAmerican
6.344800E-01
Caucasian-vs-Asian
2.967400E-01
AfricanAmerican-vs-Asian
2.947200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.95789999949348E-07
Normal-vs-Female
8.22799999999901E-05
Male-vs-Female
1.058610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.296400E-01
Normal-vs-Age(41-60Yrs)
6.45120000000166E-05
Normal-vs-Age(61-80Yrs)
1.225420E-04
Normal-vs-Age(81-100Yrs)
9.803000E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.346000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.341000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.113200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.572500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.085000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.180200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.773600E-04
Normal-vs-Daily Drinker
2.457700E-03
Normal-vs-Weekly Drinker
2.273000E-01
Normal-vs-Occasional Drinker
2.414200E-02
Normal-vs-Social Drinker
1.618980E-01
Non Drinker-vs-Daily Drinker
4.443200E-01
Non Drinker-vs-Weekly Drinker
5.881200E-01
Non Drinker-vs-Occasional Drinker
1.322040E-01
Non Drinker-vs-Social Drinker
6.468400E-01
Daily Drinker-vs-Weekly Drinker
3.003800E-01
Daily Drinker-vs-Occasional Drinker
2.226200E-01
Daily Drinker-vs-Social Drinker
2.667600E-01
Weekly Drinker-vs-Occasional Drinker
9.620000E-02
Weekly Drinker-vs-Social Drinker
9.097800E-01
Occasional Drinker-vs-Social Drinker
1.015180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.037200E-01
Normal-vs-Grade 2
3.428800E-01
Normal-vs-Grade 3
8.293900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.546000E-02
Grade 1-vs-Grade 3
6.993800E-02
Grade 1-vs-Grade 4
3.037200E-01
Grade 2-vs-Grade 3
8.938200E-01
Grade 2-vs-Grade 4
3.428800E-01
Grade 3-vs-Grade 4
8.293900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.201600E-01
Normal-vs-NonDiabetic
9.92849999992274E-07
Diabetic-vs-NonDiabetic
7.653500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.940300E-02
Normal-vs-NoPancreatitis
9.77330000040411E-07
Pancreatitis-vs-NoPancreatitis
1.127830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.502500E-02
Normal-vs-N1
6.67719999958294E-07
N0-vs-N1
4.191200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.8882999996972E-07
Normal-vs-TP53-NonMutant
2.404500E-04
TP53-Mutant-vs-TP53-NonMutant
3.299300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
